| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.087 | 0.03 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.087 | 0.03 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.31 | 0.04 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.04 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.26 | 0.04 |